Local therapy and other factors influencing site of relapse in patients with localised Ewing's sarcoma

European Journal of Cancer

Volumn 35, Issue 12, 1999, Pages 1698-1704

  Shankar, A G ^a   Pinkerton, C R ^a   Atra, A ^a   Ashley, S ^g   Lewis, I ^b   Spooner, D ^c   Cannon, S ^d   Grimer, R ^e   Cotterill, S J ^f   Craft, A W ^f  

^a Downs Road Sutton SM2 5PT   (United Kingdom)

^b Children's Day Hospital   (United Kingdom)

^c QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^d ROYAL NATIONAL ORTHOPAEDIC HOSPITAL   (United Kingdom)

^e ROYAL ORTHOPAEDIC HOSPITAL   (United Kingdom)

^f Sir James Spence Institute   (United Kingdom)

^g NONE

Author keywords

Chemotherapy; Ewing's sarcoma; Local control; Radiotherapy; Surgery

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; IFOSFAMIDE; VINCRISTINE;

ARTICLE; CANCER SURVIVAL; CHILD; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; EWING SARCOMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENCE RISK; RELAPSE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE NEOPLASMS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; DACTINOMYCIN; DISEASE-FREE SURVIVAL; DOXORUBICIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; IFOSFAMIDE; INFANT; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; SARCOMA, EWING'S; TREATMENT OUTCOME; VINCRISTINE;

EID: 0033373595     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(99)00144-6     Document Type: Article

References (40)

1. Marcus R.B., Springfield D.S., Pole G. Jr., Heare T.C., Enneking W.F., Million R.R. Late follow-up of a short term intensive regimen for Ewing's sarcoma. Am. J. Clin. Oncol. 14:1991;446-450.
2. Burgert E.O. Jr., Nesbit M.E., Garnsey L.A.et al. Multimodal therapy for management of non-pelvic localised Ewing's sarcoma of bone. intergroup study IESS-II J. Clin. Oncol. 8:1990;1514-1524.
3. Brown A.P., Fixen J.A., Plowman P.N. Local control of Ewing's sarcoma. an analysis of 67 patients Br. J. Radiat. 60:1987;261-268.
4. Terek R.M., Brien E.W., Marcove R.C., Meyers P.A., Lane J.M., Healey J.H. Treatment of femoral Ewing's sarcoma. Cancer. 78:1996;70-78.
5. Bacci G., Picci P., Gherlinzoni F.et al. Localised Ewing's sarcoma of bone ten years experience at the Instituto Orthopedico Rizzoli in 124 cases treated with multimodal therapy. Eur. J. Cancer. Clin. Oncol. 21:1985;163-173.
6. Bolek T.W., Marcus R.B. Jr., Mendenhall N.P., Scarborough M.T., Graham-Pole J. Local control and functional results after twice daily radiotherapy for Ewing's sarcoma of the extremities. Int. J. Radiat. Oncol. Biol. Phys. 35:1996;687-692.
7. Evans R.G., Nesbit M.E., Gehan E.A.et al. Multimodal therapy for the management of localised Ewing's sarcoma of pelvic and sacral bones. a report from the second intergroup study J. Clin. Oncol. 9:1991;1173-1180.
8. Kinsella T.J., Lichter A.S., Miser J., Gerber L., Glatstein E. Local treatment of Ewing's sarcoma. Radiation therapy versus surgery Cancer. Treat. Rep. 68:1984;695-701.
9. Tucker M.A., D'Angio G.J., Boice J.D.et al. Bone sarcomas linked to radiotherapy and chemotherapy in children. N. Engl. J. Med. 317:1987;588-593.
10. Gasparini M., Lombardi F., Ballerini F.et al. Long term outcome of patients with mono-ostotic Ewing's sarcoma treated with combined modality. Med. Ped. Oncol. 23:1994;406-412.
11. Strong L.C., Herson J., Osborn B.M.et al. Risk of radiation related subsequent malignant tumours in survivors of Ewing's sarcoma. J. Natl. Cancer Inst. 62:1979;1401-1406.
12. Bacci G., Toni A., Avella M.et al. Long term results in 14.4 localised Ewing's sarcoma patients treated with combined therapy. Cancer. 63:1989;1477-1486.
13. Ozaki T., Hilmann A., Hoffmann C.et al. Significance of surgical margin on the prognosis of patients with Ewing's sarcoma. Cancer. 78:1996;892-900.
14. Wilkins R.M., Pritchard D.J., Burgert E.O. Jr., Unni K.K. Ewing's sarcoma of bone. experience with 140 patients Cancer. 58:1986;2552-2555.
15. Craft A.W., Cotterill S.J., Malcolm A.J.et al. Ifosfamide containing chemotherapy in Ewing's sarcoma. The second United Kingdom Children's Cancer Study Group and Medical Research Council Ewing's Tumour Study (ET-2) J. Clin. Oncol. 16:1998;3628-3633.
16. Dunst J., Jurgens H., Sauer R.et al. Radiation therapy in Ewing's sarcoma. an update of the CESS 86 trial Int. J. Radiat. Oncol. Biol. Phys. 32:1995;919-930.
17. Kaplan E.L., Meier P. Non-parametric estimation from incomplete observation. J. Am. Stat. Assoc. 53:1958;457-481.
18. Peto R., Pike M.C., Armitage P.et al. Design and analysis of randomised clinical trials requiring prolonged observation for each patient. II. Analysis and examples Br. J. Cancer. 35:1977;1-39.
19. Cox D.R. Regression models and life tables. J. R. Stat. Soc. 34:1972;187-202.
20. Kushner B.H., Meyers P.A., Gerald W.L.et al. Very high dose short-term chemotherapy for poor risk peripheral primitive neuro ectodermal tumours, including Ewing's sarcoma in children and young adults. J. Clin. Oncol. 13:1995;2796-2804.
21. Scully S.P., Temple H.T., O'Keefe R.J., Scarborough M.T., Mankin H.J., Gebhart M.C. Role of surgical resection in Pelvic Ewing's sarcoma. J. Clin. Oncol. 13:1995;2336-2341.
22. O'Connor M.I., Pritchard D.J. Ewing's sarcoma. Prognostic factors, disease control, and the re-emerging role of surgical treatment. Clin. Orthop. Rel. Res. 262:1991;78-87.
23. Evans R.G., Nesbit M., Askin F. Local recurrence, rate of sites of metastases, and time to relapse as a function of treatment regimen, size of primary and surgical history in 62 patients presenting with non-metastatic Ewing's sarcoma of pelvic bones. Int. J. Radiat. Oncol. Biol. Phys. 11:1985;120-136.
24. Gobel V., Jurgens H., Etspuler G.et al. Prognostic significance of tumour volume in localized Ewing's sarcoma of bone in children and adolescents. J. Can. Res. Clin. Oncol. 113:1987;187-191.
25. Jurgens H., Exner U., Gadner H.et al. Multidisciplinary treatment of primary Ewing's sarcoma of bone. A 6 year experience of a European co-operative trial. Cancer. 61:1988;23-32.
26. Barbieri E., Emiliani E., Zingi G.et al. Combined therapy of localized Ewing's sarcoma of bone. analysis of results in 100 patients Int. J. Radiat. Oncol. Biol. Phys. 19:1990;1165-1170.
27. Jurgens H., Treuner J., Winkler K., Gobel U. Ifosfamide in paediatric malignancies. Semin. Oncol. 16:1989;46-50.
28. Dunst J., Sauer R., Burgers J.M.Vet al. Radiation therapy as local treatment in Ewing's sarcoma. Results of the co-operative Ewing's sarcoma studies - CESS 81 and CESS 86. Cancer. 67:1991;2818-2825.
29. Craft A.W., Cotterill S., Imeson J. Improvement in survival for Ewing's sarcoma by substitution of ifosfamide for cyclophosphamide - A UKCCSG/MRC study. Am. J. Ped. Hemat. Oncol. 15:1993;31-35.
30. Berger D.P., Frebig H.H., Winterhalter B.R., Wallbrecher E., Henss H. Pre clinical phase II study of Ifosfamide in human tumour xenografts in vivo. Cancer Chemother. Pharmacol. 26(Suppl.):1990;S7-111.
31. Goldin A. Ifosfamide in experimental tumors systems. Semin. Oncol. 9:1982;14-23.
32. Smith M.A., Ungerleider R.S., Horowitz M.E., Simon R. Influence of doxorubicin dose intensity on response and outcome for patients with osteogenic sarcoma and Ewing's sarcoma. J. Natl. Cancer Inst. 83:1991;1460-1469.
33. Craft A.W., Cotterill S.J., Bullimore J.A.et al. Long term results from the First UKCCSG Ewing's Tumour Study (ET-1). Eur. J. Cancer. 33:1997;1061-1069.
34. Sainsbury R., Howard B., Rider L.et al. Influence of clinician work load and patterns of treatment on survival from breast cancer. Lancet. 345:1995;1265-1270.
35. Blair S.L., O'Shea K.E., Orr K.K. Surgeon variablity in treating non-palpable breast cancer. surgical oncology as a value added speciality Ann. Surg. Oncol. 5:1998;28-32.
36. Atra A., Whelan J.S., Cakvagna V.et al. High-dose busulphan/melphalan with autologous stem cell rescue in Ewing's sarcoma. Bone Marrow Transplant. 20:1997;843-846.
37. Meadows A.T., Baum E., Fossati-Bellani F.et al. Second malignant neoplasms in children. an update from the late effects study group J. Clin. Oncol. 3:1985;532-538.
38. Burdach S., Jurgens H., Peters C.et al. Myeloablative radiochemotherapy and haemopoietic stem cell rescue in poor prognosis Ewing's sarcoma. J. Clin. Oncol. 11:1993;1483-1488.
39. Van der Woude H.J., Bloem J.L., Taminian A.H., Nooy M.A., Hogendoorn P.C. Classification of histopathologic changes following chemotherapy in Ewing's sarcoma of bone. Skeletal Radiol. 23:1994;501-507.
40. Picci P., Bohling T., Bacci G.et al. Chemotherapy induced tumour necrosis as a prognostic factor in localised Ewing's sarcoma of the extremities. J. Clin. Oncol. 15:1997;1553-1559.